FDA Adverse Event Malfunction Summary report: N

ACCU-CHEK SPIRIT

MDR report key: 2141025 · Received June 16, 2011

Report

Report Number
2183996-2011-01620
Event Type
Malfunction
Date Received
June 16, 2011
Date of Event
May 13, 2011
Report Date
May 18, 2011
Manufacturer
ROCHE INSULIN DELIVERY SYSTEMS INC.
Product Code
LZG
PMA / PMN Number
NA
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

THIS INCIDENT OCCURRED OUTSIDE OF THE UNITED STATES. INFORMATION CONTAINED WITHIN THIS REPORT IS ALL THAT IS AVAILABLE AT THIS TIME. IF FURTHER INFORMATION IS OBTAINED, IT WILL BE PROVIDED IN THE SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

PATIENT REPORTED, THE BOLUS DELIVERY OF THE INFUSION DEVICE IS FAULTY AND THIS RESULTED IN HYPERGLYCEMIA. PATIENT WOKE UP DURING THE NIGHT OF (B)(6) 2011, AND SHE FELT BAD AND VOMITED. SHE REALIZED SHE HAD ELEVATED BLOOD GLUCOSE (VALUE NOT PROVIDED) AND DELIVERED A CORRECTION BOLUS. BLOOD GLUCOSE DID NOT DECREASE. PATIENT CHANGED THE INFUSION SET AND ATTEMPTED TO DELIVER ADDITIONAL BOLUSES. BLOOD GLUCOSE ELEVATED ABOVE 600 MG/DL. PATIENT THEN PROGRAMMED A QUICK BOLUS. INFUSION DEVICE CONFIRMED THE EXACT AMOUNT BY PROVIDING BEEPS AND VIBRATION, BUT THE BOLUS DID NOT COUNT DOWN AS NORMAL AND THE DISPLAY RETURNED TO THE BASAL RATE. INFUSION CANNULA WAS NOT BENT, AND BLOOD GLUCOSE WAS WITHIN HER TARGET RANGE WHEN SHE WENT TO BED PRIOR TO THE EVENT. PATIENT SWITCHED TO HER BACKUP INFUSION DEVICE AND BLOOD GLUCOSE SLOWLY DECREASED. BY THE AFTERNOON, BLOOD GLUCOSE WAS WITHIN HER TARGET RANGE. INFUSION DEVICE WAS REPLACED AND REQUESTED FOR EVALUATION. THE PATIENT DID NOT REQUIRE TREATMENT FROM A HEALTH CARE PROFESSIONAL OR SECOND PARTY TO ADDRESS THE ISSUE. ADDITIONAL INFORMATION WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCU-CHEK SPIRIT INSULIN INFUSION PUMP LZG ROCHE INSULIN DELIVERY SYSTEMS INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 INSULIN| INSULIN INFUSION SET